{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T09:06:54Z","timestamp":1782205614008,"version":"3.54.5"},"reference-count":92,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatric Clinics of North America"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.psc.2017.01.002","type":"journal-article","created":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T20:19:51Z","timestamp":1488399591000},"page":"201-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Premenstrual Dysphoric Disorder"],"prefix":"10.1016","volume":"40","author":[{"given":"Teresa","family":"Lanza di Scalea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teri","family":"Pearlstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psc.2017.01.002_bib1","series-title":"Diagnostic and statistical manual of mental disorders, Fifth Edition","author":"American Psychiatric Association","year":"2013"},{"key":"10.1016\/j.psc.2017.01.002_bib2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00737-010-0201-3","article-title":"Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensus","volume":"14","author":"O'Brien","year":"2011","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1176\/appi.ajp.2012.11081302","article-title":"Premenstrual dysphoric disorder: evidence for a new category for DSM-5","volume":"169","author":"Epperson","year":"2012","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib4","doi-asserted-by":"publisher","first-page":"70","DOI":"10.4088\/JCP.13cs08368","article-title":"Addressing concerns about the inclusion of premenstrual dysphoric disorder in DSM-5","volume":"75","author":"Hartlage","year":"2014","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib5","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1097\/NMD.0000000000000128","article-title":"A\u00a0diagnostic and statistical manual of mental disorders history of premenstrual dysphoric disorder","volume":"202","author":"Zachar","year":"2014","journal-title":"J\u00a0Nerv Ment Dis"},{"key":"10.1016\/j.psc.2017.01.002_bib6","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s11673-014-9567-7","article-title":"Is premenstrual dysphoric disorder really a disorder?","volume":"12","author":"Browne","year":"2015","journal-title":"J\u00a0Bioeth Inq"},{"key":"10.1016\/j.psc.2017.01.002_bib7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00737-005-0103-y","article-title":"Daily record of severity of problems (DRSP): reliability and validity","volume":"9","author":"Endicott","year":"2006","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s00737-003-0018-4","article-title":"The premenstrual symptoms screening tool (PSST) for clinicians","volume":"6","author":"Steiner","year":"2003","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s00737-010-0202-2","article-title":"The premenstrual symptoms screening tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents","volume":"14","author":"Steiner","year":"2011","journal-title":"Arch Womens Ment Health"},{"issue":"6","key":"10.1016\/j.psc.2017.01.002_bib10","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1007\/s00737-016-0631-7","article-title":"Fourth consensus of the International Society for Premenstrual Disorders (ISPMD): auditable standards for diagnosis and management of premenstrual disorder","volume":"19","author":"Ismaili","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib11","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s40272-013-0018-4","article-title":"Premenstrual dysphoric disorder and severe premenstrual syndrome in adolescents","volume":"15","author":"Rapkin","year":"2013","journal-title":"Paediatr Drugs"},{"key":"10.1016\/j.psc.2017.01.002_bib12","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s00737-013-0346-y","article-title":"ISPMD consensus on the management of premenstrual disorders","volume":"16","author":"Nevatte","year":"2013","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib13","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1017\/S0033291701004925","article-title":"Prevalence, incidence and stability of premenstrual dysphoric disorder in the community","volume":"32","author":"Wittchen","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.psc.2017.01.002_bib14","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02191520","article-title":"The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study","volume":"243","author":"Merikangas","year":"1993","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.psc.2017.01.002_bib15","first-page":"1","article-title":"The prevalence, impairment, impact, and burden of premenstrual dysphoric disorder (PMS\/PMDD)","volume":"28","author":"Halbreich","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psc.2017.01.002_bib16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/07399332.2011.610530","article-title":"Intercountry assessment of the impact of severe premenstrual disorders on work and daily activities","volume":"33","author":"Heinemann","year":"2012","journal-title":"Health Care Women Int"},{"key":"10.1016\/j.psc.2017.01.002_bib17","doi-asserted-by":"publisher","first-page":"e415","DOI":"10.4088\/JCP.15m09779","article-title":"History of postpartum depression in a clinic-based sample of women with premenstrual dysphoric disorder","volume":"77","author":"Kepple","year":"2016","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib18","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s00737-011-0232-4","article-title":"Posttraumatic stress disorder and trauma characteristics are correlates of premenstrual dysphoric disorder","volume":"14","author":"Pilver","year":"2011","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib19","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.4088\/JCP.v65n1004","article-title":"Risk factors for premenstrual dysphoric disorder in a community sample of young women: the role of traumatic events and posttraumatic stress disorder","volume":"65","author":"Perkonigg","year":"2004","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00737-011-0212-8","article-title":"Personality disorders in women with severe premenstrual syndrome","volume":"14","author":"Sassoon","year":"2011","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib21","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jpsychires.2010.01.013","article-title":"Estrogen receptor alpha (ESR-1) associations with psychological traits in women with PMDD and controls","volume":"44","author":"Miller","year":"2010","journal-title":"J\u00a0Psychiatr Res"},{"key":"10.1016\/j.psc.2017.01.002_bib22","doi-asserted-by":"publisher","first-page":"e0148653","DOI":"10.1371\/journal.pone.0148653","article-title":"Personality traits of suicidality are associated with premenstrual syndrome and premenstrual dysphoric disorder in a suicidal women sample","volume":"11","author":"Ducasse","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.psc.2017.01.002_bib23","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00127-012-0509-6","article-title":"Prevalence, correlates, comorbidities, and suicidal tendencies of premenstrual dysphoric disorder in a nationwide sample of Korean women","volume":"47","author":"Hong","year":"2012","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.psc.2017.01.002_bib24","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s00127-012-0548-z","article-title":"Premenstrual dysphoric disorder as a correlate of suicidal ideation, plans, and attempts among a nationally representative sample","volume":"48","author":"Pilver","year":"2013","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.psc.2017.01.002_bib25","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s00737-012-0323-x","article-title":"Examination of premenstrual symptoms as a risk factor for depression in postpartum women","volume":"16","author":"Buttner","year":"2013","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/archpsyc.61.1.62","article-title":"Hormones and menopausal status as predictors of depression in women in transition to menopause","volume":"61","author":"Freeman","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1001\/archpsyc.56.5.418","article-title":"Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles","volume":"56","author":"Harlow","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib28","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1176\/appi.ajp.163.1.133","article-title":"Premenstrual symptoms and perimenopausal depression","volume":"163","author":"Richards","year":"2006","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1056\/NEJM199801223380401","article-title":"Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome","volume":"338","author":"Schmidt","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.psc.2017.01.002_bib30","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.pbb.2006.05.020","article-title":"Neuroactive steroids and affective disorders","volume":"84","author":"Eser","year":"2006","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.psc.2017.01.002_bib31","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.pneurobio.2013.09.003","article-title":"The role of allopregnanolone in depression and anxiety","volume":"113","author":"Schule","year":"2014","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.psc.2017.01.002_bib32","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1471-4159.2006.04055.x","article-title":"Changes in expression of the delta subunit of the GABA (A) receptor and in receptor function induced by progesterone exposure and withdrawal","volume":"99","author":"Mostallino","year":"2006","journal-title":"J\u00a0Neurochem"},{"key":"10.1016\/j.psc.2017.01.002_bib33","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1007\/s00213-016-4258-1","article-title":"Women with premenstrual dysphoric disorder have altered sensitivity to allopregnanolone over the menstrual cycle compared to controls-a pilot study","volume":"233","author":"Timby","year":"2016","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psc.2017.01.002_bib34","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.psyneuen.2014.10.025","article-title":"Isoallopregnanolone antagonize allopregnanolone-induced effects on saccadic eye velocity and self-reported sedation in humans","volume":"52","author":"Bengtsson","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.psc.2017.01.002_bib35","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1007\/s00213-014-3572-8","article-title":"Neurosteroid, GABAergic and hypothalamic pituitary adrenal (HPA) axis regulation: what is the current state of knowledge in humans?","volume":"231","author":"Crowley","year":"2014","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.psc.2017.01.002_bib36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s11920-015-0628-3","article-title":"Premenstrual dysphoric disorder: epidemiology and treatment","volume":"17","author":"Hantsoo","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.psc.2017.01.002_bib37","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1038\/npp.2015.246","article-title":"5\u03b1-reductase inhibition prevents the luteal phase increase in plasma allopregnanolone levels and mitigates symptoms in women with premenstrual dysphoric disorder","volume":"41","author":"Martinez","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psc.2017.01.002_bib38","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.pneurobio.2013.07.005","article-title":"Allopregnanolone and mood disorders","volume":"113","author":"Backstrom","year":"2014","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.psc.2017.01.002_bib39","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1002\/cphy.c150014","article-title":"Reproductive steroid regulation of mood and behavior","volume":"6","author":"Schiller","year":"2016","journal-title":"Compr Physiol"},{"key":"10.1016\/j.psc.2017.01.002_bib40","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2165\/00023210-200115040-00003","article-title":"The role of central serotonergic dysfunction in the aetiology of premenstrual dysphoric disorder: therapeutic implications","volume":"15","author":"Parry","year":"2001","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psc.2017.01.002_bib41","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/S0140-6736(08)60527-9","article-title":"Premenstrual syndrome","volume":"371","author":"Yonkers","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.psc.2017.01.002_bib42","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.npep.2015.11.003","article-title":"Effect of curcumin on serum brain-derived neurotrophic factor levels in women with premenstrual syndrome: a randomized, double-blind, placebo-controlled trial","volume":"56","author":"Fanaei","year":"2016","journal-title":"Neuropeptides"},{"issue":"6","key":"10.1016\/j.psc.2017.01.002_bib43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001396.pub3","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome","author":"Marjoribanks","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psc.2017.01.002_bib44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1016\/S0006-3223(98)00070-5","article-title":"Can the antidysphoric and anxiolytic profiles of selective serotonin reuptake inhibitors be related to their ability to increase brain 3 alpha, 5 alpha-tetrahydroprogesterone (allopregnanolone) availability?","volume":"44","author":"Guidotti","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib45","doi-asserted-by":"publisher","first-page":"13512","DOI":"10.1073\/pnas.96.23.13512","article-title":"Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes","volume":"96","author":"Griffin","year":"1999","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.psc.2017.01.002_bib46","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1017\/S0033291701004901","article-title":"Genetic and environmental influences on premenstrual symptoms in an Australian twin sample","volume":"32","author":"Treloar","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.psc.2017.01.002_bib47","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.biopsych.2006.12.019","article-title":"Risk for premenstrual dysphoric disorder is associated with genetic variation in ESR1, the estrogen receptor alpha gene","volume":"62","author":"Huo","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib48","doi-asserted-by":"publisher","first-page":"181.e1-e5","DOI":"10.1016\/j.ajog.2010.02.043","article-title":"Analysis of the serotonin transporter promoter rs25531 polymorphism in premenstrual dysphoric disorder","volume":"203","author":"Magnay","year":"2010","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.psc.2017.01.002_bib49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.jad.2007.01.031","article-title":"Facial emotion discrimination across the menstrual cycle in women with premenstrual dysphoric disorder (PMDD) and controls","volume":"104","author":"Rubinow","year":"2007","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.psc.2017.01.002_bib50","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jad.2007.09.015","article-title":"Toward a functional neuroanatomy of premenstrual dysphoric disorder","volume":"108","author":"Protopopescu","year":"2008","journal-title":"J\u00a0Affect Disord"},{"key":"10.1016\/j.psc.2017.01.002_bib51","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1176\/appi.ajp.2012.12030385","article-title":"Abnormalities of dorsolateral prefrontal function in women with premenstrual dysphoric disorder: a multimodal neuroimaging study","volume":"170","author":"Baller","year":"2013","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib52","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s11920-015-0619-4","article-title":"Neuroimaging the menstrual cycle and premenstrual dysphoric disorder","volume":"17","author":"Comasco","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.psc.2017.01.002_bib53","doi-asserted-by":"publisher","first-page":"523","DOI":"10.2165\/00023210-200620070-00001","article-title":"Are there differential symptom profiles that improve in response to different pharmacological treatments of premenstrual syndrome\/premenstrual dysphoric disorder?","volume":"20","author":"Halbreich","year":"2006","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psc.2017.01.002_bib54","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1097\/AOG.0b013e31816fd73b","article-title":"Selective serotonin reuptake inhibitors for premenstrual syndrome and premenstrual dysphoric disorder: a meta-analysis","volume":"111","author":"Shah","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.psc.2017.01.002_bib55","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1258\/mi.2012.012010","article-title":"Psychotropic medications and other non-hormonal treatments for premenstrual disorders","volume":"18","author":"Pearlstein","year":"2012","journal-title":"Menopause Int"},{"key":"10.1016\/j.psc.2017.01.002_bib56","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s40263-013-0069-7","article-title":"Luteal phase and symptom-onset dosing of SSRIs\/SNRIs in the treatment of premenstrual dysphoria: clinical evidence and rationale","volume":"27","author":"Steiner","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.psc.2017.01.002_bib57","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1002\/da.21959","article-title":"Rapid response to fluoxetine in women with premenstrual dysphoric disorder","volume":"29","author":"Steinberg","year":"2012","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.psc.2017.01.002_bib58","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1001\/jamapsychiatry.2015.1472","article-title":"Symptom-onset dosing of sertraline for the treatment of premenstrual dysphoric disorder: a randomized clinical trial","volume":"72","author":"Yonkers","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib59","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1097\/AOG.0b013e318236edf2","article-title":"Clinical subtypes of premenstrual syndrome and responses to sertraline treatment","volume":"118","author":"Freeman","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.psc.2017.01.002_bib60","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1001\/archgenpsychiatry.2008.547","article-title":"Time to relapse after short- or long-term treatment of severe premenstrual syndrome with sertraline","volume":"66","author":"Freeman","year":"2009","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib61","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.4088\/JCP.v68n1218","article-title":"Treatment of premenstrual worsening of depression with adjunctive oral contraceptive pills: a preliminary report","volume":"68","author":"Joffe","year":"2007","journal-title":"J\u00a0Clin Psychiatry"},{"key":"10.1016\/j.psc.2017.01.002_bib62","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s00737-012-0313-z","article-title":"Comorbid bipolar disorder and premenstrual dysphoric disorder: real patients, unanswered questions","volume":"16","author":"Frey","year":"2013","journal-title":"Arch Womens Ment Health"},{"issue":"2","key":"10.1016\/j.psc.2017.01.002_bib63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006586.pub4","article-title":"Oral contraceptives containing drospirenone for premenstrual syndrome","author":"Lopez","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psc.2017.01.002_bib64","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1097\/01.AOG.0000175834.77215.2e","article-title":"Efficacy of a new low-dose oral contraceptive with drospirenone in premenstrual dysphoric disorder","volume":"106","author":"Yonkers","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.psc.2017.01.002_bib65","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.contraception.2005.08.021","article-title":"Treatment of premenstrual dysphoric disorder with a new drospirenone-containing oral contraceptive formulation","volume":"72","author":"Pearlstein","year":"2005","journal-title":"Contraception"},{"key":"10.1016\/j.psc.2017.01.002_bib66","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.contraception.2011.09.010","article-title":"An overview of four studies of a continuous oral contraceptive (levonorgestrel 90 mcg\/ethinyl estradiol 20 mcg) on premenstrual dysphoric disorder and premenstrual syndrome","volume":"85","author":"Freeman","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.psc.2017.01.002_bib67","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.contraception.2011.05.008","article-title":"Continuous oral levonorgestrel\/ethinyl estradiol for treating premenstrual dysphoric disorder","volume":"85","author":"Halbreich","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.psc.2017.01.002_bib68","doi-asserted-by":"crossref","first-page":"487143","DOI":"10.1155\/2013\/487143","article-title":"A\u00a0comparative efficacy of low-dose combined oral contraceptives containing desogestrel and drospirenone in premenstrual symptoms","volume":"2013","author":"Wichianpitaya","year":"2013","journal-title":"Obstet Gynecol Int"},{"key":"10.1016\/j.psc.2017.01.002_bib69","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1471-0528.2004.00135.x","article-title":"The effectiveness of GnRHa with and without 'add-back' therapy in treating premenstrual syndrome: a meta analysis","volume":"111","author":"Wyatt","year":"2004","journal-title":"BJOG"},{"key":"10.1016\/j.psc.2017.01.002_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1258\/mi.2012.012015","article-title":"Treatment of premenstrual disorders by suppression of ovulation by transdermal estrogens","volume":"18","author":"Studd","year":"2012","journal-title":"Menopause Int"},{"issue":"3","key":"10.1016\/j.psc.2017.01.002_bib71","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003415.pub4","article-title":"Progesterone for premenstrual syndrome","author":"Ford","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.psc.2017.01.002_bib72","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00404-012-2594-x","article-title":"Premenstrual syndrome: a single-blind study of treatment with buspirone versus fluoxetine","volume":"287","author":"Nazari","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.psc.2017.01.002_bib73","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1097\/WNF.0b013e318279ee1f","article-title":"Lamotrigine augmentation in premenstrual dysphoric disorder: a case report","volume":"36","author":"Sepede","year":"2013","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.psc.2017.01.002_bib74","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00737-008-0014-9","article-title":"Levetiracetam for treatment of premenstrual dysphoric disorder: a pilot, open-label study","volume":"11","author":"Kayatekin","year":"2008","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib75","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/hup.2494","article-title":"Double-blind, placebo-controlled pilot study of adjunctive quetiapine SR in the treatment of PMS\/PMDD","volume":"30","author":"Jackson","year":"2015","journal-title":"Hum Psychopharmacol"},{"key":"10.1016\/j.psc.2017.01.002_bib76","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0002-9378(98)70377-1","article-title":"Calcium carbonate and the premenstrual syndrome: effects on premenstrual and menstrual symptoms. Premenstrual Syndrome Study Group","volume":"179","author":"Thys-Jacobs","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.psc.2017.01.002_bib77","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1097\/JCP.0b013e31829c7697","article-title":"A\u00a0pilot study to compare fluoxetine, calcium and placebo in the treatment of premenstrual syndrome","volume":"33","author":"Yonkers","year":"2013","journal-title":"J\u00a0Clin Psychopharmacol"},{"key":"10.1016\/j.psc.2017.01.002_bib78","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.ejogrb.2016.01.015","article-title":"Calcium versus oral contraceptive pills containing drospirenone for the treatment of mild to moderate premenstrual syndrome: a double blind randomized placebo controlled trial","volume":"198","author":"Shehata","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.psc.2017.01.002_bib79","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1136\/bmj.318.7195.1375","article-title":"Efficacy of vitamin B-6 in the treatment of premenstrual syndrome: systematic review","volume":"318","author":"Wyatt","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/j.psc.2017.01.002_bib80","first-page":"e407","article-title":"Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review","volume":"16","author":"Whelan","year":"2009","journal-title":"Can J Clin Pharmacol"},{"key":"10.1016\/j.psc.2017.01.002_bib81","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3109\/0167482X.2010.538102","article-title":"Herbal treatments for alleviating premenstrual symptoms: a systematic review","volume":"32","author":"Dante","year":"2011","journal-title":"J\u00a0Psychosom Obstet Gynaecol"},{"key":"10.1016\/j.psc.2017.01.002_bib82","first-page":"562","article-title":"Vitex agnus-castus extracts for female reproductive disorders: a systematic review of clinical trials","volume":"79","author":"van Die","year":"2013","journal-title":"Planta Med"},{"key":"10.1016\/j.psc.2017.01.002_bib83","doi-asserted-by":"publisher","first-page":"259345","DOI":"10.1155\/2010\/259345","article-title":"Sleep, hormones, and circadian rhythms throughout the menstrual cycle in healthy women and women with premenstrual dysphoric disorder","volume":"2010","author":"Shechter","year":"2010","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.psc.2017.01.002_bib84","doi-asserted-by":"publisher","first-page":"415","DOI":"10.3109\/07420528.2011.567365","article-title":"Reduced phase-advance of plasma melatonin after bright morning light in the luteal, but not follicular, menstrual cycle phase in premenstrual dysphoric disorder: an extended study","volume":"28","author":"Parry","year":"2011","journal-title":"Chronobiol Int"},{"key":"10.1016\/j.psc.2017.01.002_bib85","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1111\/j.1471-0528.2011.02994.x","article-title":"Acupuncture for premenstrual syndrome: a systematic review and meta-analysis of randomised controlled trials","volume":"118","author":"Kim","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/j.psc.2017.01.002_bib86","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1089\/jwh.2008.1098","article-title":"Exercise and premenstrual symptomatology: a comprehensive review","volume":"18","author":"Daley","year":"2009","journal-title":"J\u00a0Womens Health"},{"key":"10.1016\/j.psc.2017.01.002_bib87","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1111\/j.1365-2850.2012.01965.x","article-title":"The effect of cognitive behavioural psycho-education on premenstrual syndrome and related symptoms","volume":"20","author":"Taghizadeh","year":"2013","journal-title":"J\u00a0Psychiatr Ment Health Nurs"},{"key":"10.1016\/j.psc.2017.01.002_bib88","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000162296","article-title":"Psychological intervention for premenstrual syndrome: a meta-analysis of randomized controlled trials","volume":"78","author":"Busse","year":"2009","journal-title":"Pyschother Psychosom"},{"key":"10.1016\/j.psc.2017.01.002_bib89","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00737-009-0052-y","article-title":"Cognitive-behavioral therapy for premenstrual syndrome and premenstrual dysphoric disorder: a systematic review","volume":"12","author":"Lustyk","year":"2009","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib90","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1007\/s10880-012-9299-y","article-title":"Cognitive-behavioral and pharmacological interventions for premenstrual syndrome or premenstrual dysphoric disorder: a meta-analysis","volume":"19","author":"Kleinstauber","year":"2012","journal-title":"J\u00a0Clin Psychol Med Settings"},{"issue":"5","key":"10.1016\/j.psc.2017.01.002_bib91","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1007\/s00737-016-0634-4","article-title":"Emotion regulation in women with premenstrual dysphoric disorder","volume":"19","author":"Petersen","year":"2016","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/j.psc.2017.01.002_bib92","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1007\/s12671-015-0397-4","article-title":"Mindfulness-based stress reduction as a promising intervention for amelioration of premenstrual dysphoric disorder symptoms","volume":"6","author":"Bluth","year":"2015","journal-title":"Mindfulness"}],"container-title":["Psychiatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X17300059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0193953X17300059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,19]],"date-time":"2019-09-19T06:35:32Z","timestamp":1568874932000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0193953X17300059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":92,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0193953X17300059"],"URL":"https:\/\/doi.org\/10.1016\/j.psc.2017.01.002","relation":{},"ISSN":["0193-953X"],"issn-type":[{"value":"0193-953X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Premenstrual Dysphoric Disorder","name":"articletitle","label":"Article Title"},{"value":"Psychiatric Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psc.2017.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}